{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:26:49Z","timestamp":1795210009800,"version":"4.10.3"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To provide an overview of the current research in identifying homogeneous subgroups and phenotypes in ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>In recent years, investigations have used either physiology, clinical data, biomarkers or a combination of these to stratify patients with ARDS into distinct subgroups with divergent clinical outcomes. In some studies, there has also been evidence of differential treatment response within subgroups. Physiologic approaches include stratification based on P\/F ratio and ventilatory parameters; stratification based on P\/F ratio is already being employed in clinical trials. Clinical approaches include stratification based on ARDS risk factor or direct vs. indirect ARDS. Combined clinical and biological data has been used to identify two phenotypes across five cohorts of ARDS, termed hyperinflammatory and hypoinflammatory. These phenotypes have widely divergent clinical outcomes and differential response to mechanical ventilation, fluid therapy, and simvastatin in secondary analysis of completed trials. Next steps in the field include prospective validation of inflammatory phenotypes and integration of high-dimensional \u2018omics\u2019 data into our understanding of ARDS heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Identification of distinct subgroups or phenotypes in ARDS may impact future conduct of clinical trials and can enhance our understanding of the disorder, with potential future clinical implications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000571","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T07:05:55Z","timestamp":1544425555000},"page":"12-20","source":"Crossref","is-referenced-by-count":116,"title":["Phenotypes in acute respiratory distress syndrome: moving towards precision medicine"],"prefix":"10.1097","volume":"25","author":[{"given":"Pratik","family":"Sinha","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine"},{"name":"Department of Anesthesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Calfee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine"},{"name":"Department of Anesthesia"},{"name":"Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Force","year":"2012","journal-title":"JAMA"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(17)30188-1","article-title":"Clinical trials in acute respiratory distress syndrome: challenges and opportunities","volume":"5","author":"Matthay","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"(3 Pt 1)","key":"R3-20230913","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of two fluid-management strategies in acute lung injury","volume":"354","author":"Wiedemann","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"Neuromuscular blockers in early acute respiratory distress syndrome","volume":"363","author":"Papazian","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Guerin","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.201709-1804OC","article-title":"Reclassifying acute respiratory distress syndrome","volume":"197","author":"Maiolo","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMsa1410639","article-title":"Driving pressure and survival in the acute respiratory distress syndrome","volume":"372","author":"Amato","year":"2015","journal-title":"N Engl J Med"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMoa012835","article-title":"Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome","volume":"346","author":"Nuckton","year":"2002","journal-title":"N Engl J Med"},{"key":"R14-20230913","article-title":"Physiological analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome","author":"Sinha","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/01.CCM.0000280434.33451.87","article-title":"Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders","volume":"35","author":"Calfee","year":"2007","journal-title":"Crit Care Med"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/ajrccm.158.1.9708031","article-title":"Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?","volume":"158","author":"Gattinoni","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.213.2.r99nv42545","article-title":"Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations","volume":"213","author":"Goodman","year":"1999","journal-title":"Radiology"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00000542-200702000-00007","article-title":"Alveolar recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome: comparison using pressure-volume curve or static compliance","volume":"106","author":"Thille","year":"2007","journal-title":"Anesthesiology"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1378\/chest.14-2454","article-title":"Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies","volume":"147","author":"Calfee","year":"2015","journal-title":"Chest"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chest.2016.09.004","article-title":"Clinical predictors of hospital mortality differ between direct and indirect ARDS","volume":"151","author":"Luo","year":"2017","journal-title":"Chest"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/CCM.0b013e3181760e5d","article-title":"Recruitment maneuver in pulmonary and extrapulmonary experimental acute lung injury","volume":"36","author":"Riva","year":"2008","journal-title":"Crit Care Med"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1097\/CCM.0b013e3181847b43","article-title":"Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice","volume":"36","author":"Leite-Junior","year":"2008","journal-title":"Crit Care Med"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0929-6646(09)60392-2","article-title":"Timing of acute respiratory distress syndrome onset is related to patient outcome","volume":"108","author":"Liao","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00134-016-4638-3","article-title":"Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study","volume":"43","author":"Zhang","year":"2017","journal-title":"Intensive Care Med"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005373-199903000-00001","article-title":"Early and late acute respiratory distress syndrome: two distinct clinical entities","volume":"46","author":"Croce","year":"1999","journal-title":"J Trauma"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1513\/AnnalsATS.201308-280OC","article-title":"Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma","volume":"11","author":"Reilly","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccm.2014.08.004","article-title":"Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury","volume":"35","author":"Shaver","year":"2014","journal-title":"Clin Chest Med"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc13080","article-title":"Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome","volume":"17","author":"Ware","year":"2013","journal-title":"Crit Care"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00003246-199609000-00004","article-title":"Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis","volume":"24","author":"Miller","year":"1996","journal-title":"Crit Care Med"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thoraxjnl-2017-211443","article-title":"Selective tumour necrosis factor receptor-1 inhibition in acute lung injury: a new hope or a false dawn?","volume":"73","author":"Sinha","year":"2018","journal-title":"Thorax"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/cc6846","article-title":"Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury","volume":"12","author":"McClintock","year":"2008","journal-title":"Crit Care"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.201208-1460OC","article-title":"Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients","volume":"187","author":"Agrawal","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00134-008-1235-0","article-title":"Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury","volume":"35","author":"Calfee","year":"2009","journal-title":"Intensive Care Med"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/thorax.58.11.983","article-title":"Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury","volume":"58","author":"Eisner","year":"2003","journal-title":"Thorax"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00134-018-5327-1","article-title":"Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data","volume":"44","author":"Jabaudon","year":"2018","journal-title":"Intensive Care Med"},{"key":"R36-20230913","first-page":"1821","article-title":"Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury\/acute respiratory distress syndrome","volume":"35","author":"Ware","year":"2007","journal-title":"Crit Care Med"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCC.0000000000000048","article-title":"Biomarkers in acute respiratory distress syndrome","volume":"20","author":"Binnie","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"R38-20230913","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1164\/rccm.201501-0020OC","article-title":"Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome","volume":"192","author":"Jabaudon","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chest.2016.03.016","article-title":"Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study","volume":"150","author":"Mrozek","year":"2016","journal-title":"Chest"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"R41-20230913","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"R43-20230913","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20230913","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"R45-20230913","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"R46-20230913","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"R47-20230913","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an antiinterleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"R48-20230913","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R49-20230913","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"R50-20230913","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/thoraxjnl-2017-211090","article-title":"Stability of ARDS subphenotypes over time in two randomised controlled trials","volume":"73","author":"Delucchi","year":"2018","journal-title":"Thorax"},{"key":"R51-20230913","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","article-title":"Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy","volume":"195","author":"Famous","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R52-20230913","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"key":"R53-20230913","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R54-20230913","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","article-title":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study","volume":"44","author":"Sinha","year":"2018","journal-title":"Intensive Care Med"},{"key":"R55-20230913","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","article-title":"Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis","volume":"72","author":"Bos","year":"2017","journal-title":"Thorax"},{"key":"R56-20230913","first-page":"A4181","article-title":"Building a parsimonious model using biomarker and clinical data to identify subphenotypes in acute respiratory distress syndrome. B95 critical care: biomarkers in ARDS and sepsis from genes to microbiome","volume":"197","author":"Sinha","year":"2018","journal-title":"Am J Resp Crit Care Med"},{"key":"R57-20230913","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature15816","article-title":"Building the foundation for genomics in precision medicine","volume":"526","author":"Aronson","year":"2015","journal-title":"Nature"},{"key":"R58-20230913","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R59-20230913","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"R60-20230913","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(08)60105-1","article-title":"Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial","volume":"371","author":"Girard","year":"2008","journal-title":"Lancet"},{"key":"R61-20230913","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.201208-1501OC","article-title":"IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist","volume":"187","author":"Meyer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R62-20230913","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCM.0000000000002749","article-title":"Mortality benefit of recombinant human interleukin-1 receptor antagonist for sepsis varies by initial interleukin-1 receptor antagonist plasma concentration","volume":"46","author":"Meyer","year":"2018","journal-title":"Crit Care Med"},{"key":"R63-20230913","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R64-20230913","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.201608-1685OC","article-title":"Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia","volume":"196","author":"Burnham","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R65-20230913","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R66-20230913","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","article-title":"Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R67-20230913","doi-asserted-by":"crossref","first-page":"L703","DOI":"10.1152\/ajplung.00438.2016","article-title":"Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset","volume":"312","author":"Rogers","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R68-20230913","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40635-017-0155-0","article-title":"Whole blood microRNA markers are associated with acute respiratory distress syndrome","volume":"5","author":"Zhu","year":"2017","journal-title":"Intensive Care Med Exp"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075198-201902000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:16:30Z","timestamp":1694618190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075198-201902000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000571","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}